Clinical Trials Browser

Phase 2 × High-Intensity Interval Training × Clear all

NCT04593862 2024-09-19

BRAVE

Phase 2 Completed

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Motor Activity